ArticleBiomolecules & biomedicine2025
Green synthesis of plant-derived ZnO nanoparticles: Characterization, pharmacokinetics, molecular interactions, and
Article in Biomolecules & biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ginger phytochemical corona enhances hemocompatibility of metal oxide nanoparticles for blood-contacting applications.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nowadays, nanoparticles (NPs) are used to counteract various medicinal and industrial problems. This study aimed to biosynthesize zinc oxide NPs (ZnONPs) from the plant species Aloe vera L., Peganum harmala L., Retama monosperma L., and Thymelaea hirsuta L. The biosynthesized ZnONPs were referred to as "Thymhirs.bio-ZnONP," "Aloever.bio-ZnONP," "Retam.bio-ZnONP," and "Harm.bio-ZnONP." A UV-visible spectrophotometer, granulometry, Fourier transform infrared spectroscopy, and electron paramagnetic resonance were used for physicochemical characterization. Pharmacokinetics and antimicrobial effects were explored using combined in vitro and computational assays. An abundance of phenolic acids and flavonoids was observed, particularly rutin, quinic acid, apigenin-7-O-glucoside, and cirsiliol, which may act as reducing, stabilizing, and capping agents in the biosynthesis. ZnONPs demonstrated strong antimicrobial activity against various bacterial, fungal, and yeast strains, highlighting their potential medicinal applications. This inhibitory activity can be attributed to the effect of the plant-based ZnO nanosized particles more than to the plant extracts or Zn salt. Computational modeling revealed that the identified phytochemicals (phenolic acids and flavonoids) bound Tyrosyl-tRNA Synthetase (TyrRS) from S. aureus (1JIJ), aspartic proteinase from C. albicans (2QZW), and wheat germ agglutinin (2UVO) with considerable affinities, which, together with molecular interactions and pharmacokinetics, satisfactorily support the in vitro antimicrobial findings. This study lays the groundwork for future research and pharmaceutical explorations aimed at harnessing the likely beneficial properties of green-synthesized ZnONPs for medicinal and therapeutic purposes, particularly their antimicrobial effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.